Therapeutic potential of gastrodin in Parkinson’s disease: mechanistic insights into the Nrf2/ARE, p38 MAPK, and Bax/Bad signaling pathways
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-13178-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 19.11.2026. Verfasst von Anish Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India. Hauptthemen laut MEDLINE: Benzyl Alcohols, Glucosides, Parkinson Disease. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
- University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India. lovedeep992s@gmail.com.
ORCID-Profile: Anish Singh, Lovedeep Singh
Zitieren
APA
Singh, A., & Singh, L. (2026). Therapeutic potential of gastrodin in Parkinson’s disease: mechanistic insights into the Nrf2/ARE, p38 MAPK, and Bax/Bad signaling pathways. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13178-8
Vancouver
Singh A, Singh L. Therapeutic potential of gastrodin in Parkinson’s disease: mechanistic insights into the Nrf2/ARE, p38 MAPK, and Bax/Bad signaling pathways. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13178-8
BibTeX
@article{Singh2026,
author = {Singh, Anish and Singh, Lovedeep},
title = {Therapeutic potential of gastrodin in Parkinson’s disease: mechanistic insights into the Nrf2/ARE, p38 MAPK, and Bax/Bad signaling pathways},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-13178-8}
}
EUVIMED